COSCIENS Biopharma Inc. (CSCI) — Capital Reinvestment Ratio
COSCIENS Biopharma Inc. (CSCI) has a Capital Reinvestment Ratio of 0.06x as of September 2023, meaning it reinvests 0% of its operating cash flow ($144.00K) in capital expenditures ($8.92K). See COSCIENS Biopharma Inc. net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
COSCIENS Biopharma Inc. Capital Reinvestment Ratio (2003–2022)
This chart tracks COSCIENS Biopharma Inc.'s Capital Reinvestment Ratio across 13 annual periods. Check CSCI cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year Capital Reinvestment Ratio for COSCIENS Biopharma Inc. from 2003 to 2022. For live market cap and broader valuation context, see COSCIENS Biopharma Inc. (CSCI) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | $5.23 Million | $10.57K | ▼ -99.0% |
| 2021 | 0.20x | $2.75 Million | $555.99K | ▲ +45.3% |
| 2020 | 0.14x | $3.49 Million | $485.46K | ▲ +2689786.0% |
| 2019 | 0.00x | $675.29K | $3.49 | ▼ -100.0% |
| 2017 | 2.55x | $1.25 Million | $3.20 Million | ▲ +150.5% |
| 2016 | 1.02x | $3.63 Million | $3.71 Million | ▼ -3.5% |
| 2015 | 1.06x | $2.87 Million | $3.03 Million | ▼ -51.2% |
| 2014 | 2.16x | $1.84 Million | $3.98 Million | ▼ -54.0% |
| 2013 | 4.70x | $460.21K | $2.16 Million | ▲ +2917.9% |
| 2011 | 0.16x | $791.62K | $123.30K | ▼ -12.1% |
| 2010 | 0.18x | $479.50K | $85.01K | ▼ -62.7% |
| 2006 | 0.47x | $140.59K | $66.73K | ▼ -74.9% |
| 2003 | 1.89x | $54.42K | $103.05K | — |